BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16439699)

  • 1. Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy.
    Jericó C; Knobel H; Calvo N; Sorli ML; Guelar A; Gimeno-Bayón JL; Saballs P; López-Colomés JL; Pedro-Botet J
    Stroke; 2006 Mar; 37(3):812-7. PubMed ID: 16439699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy.
    Jeong SJ; Kim CO; Song YG; Baek JH; Kim SB; Jin SJ; Ku NS; Han SH; Choi JY; Lee HC; Kim JM
    Atherosclerosis; 2011 Dec; 219(2):778-83. PubMed ID: 21872861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma klotho levels were inversely associated with subclinical carotid atherosclerosis in HIV-infected patients receiving combined antiretroviral therapy.
    Jeong SJ; Song JE; Kim SB; Kim HW; Ku NS; Han SH; Choi JY; Song YG; Cha BS; Kim JM
    AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1575-81. PubMed ID: 23941507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.
    Sarfo FS; Nichols M; Agyei B; Singh A; Ennin E; Nyantakyi AD; Asibey SO; Tagge R; Gebregziabher M; Jenkins C; Ovbiagele B
    J Neurol Sci; 2019 Feb; 397():103-111. PubMed ID: 30599299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.
    De Socio GV; Martinelli C; Ricci E; Orofino G; Valsecchi L; Vitiello P; Martinelli L; Quirino T; Maggi P; Bonfanti P;
    Int J STD AIDS; 2010 Apr; 21(4):267-72. PubMed ID: 20378899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low CD4 Cell Counts Are Associated with Carotid Plaque and Intima-Media Thickness in Virologically Suppressed HIV-Infected Asians Older Than 50 Years.
    Siwamogsatham S; Chutinet A; Vongsayan P; Samajarn J; Putcharoen O; Aponpong T; Hiransuthikul A; Gatechompol S; Han WM; Chattranukulchai P; Kerr SJ; Ruxrungtham K; Avihingsanon A;
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1160-1169. PubMed ID: 31530175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy.
    Calza L; Borderi M; Granozzi B; Malosso P; Pancaldi L; Bon I; Re MC
    HIV Res Clin Pract; 2019 Dec; 20(6):131-139. PubMed ID: 32065065
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection.
    Calza L; Verucchi G; Pocaterra D; Pavoni M; Alfieri A; Cicognani A; Manfredi R; Serra C; Chiodo F
    Int J STD AIDS; 2009 Oct; 20(10):683-9. PubMed ID: 19815912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.
    Johnsen S; Dolan SE; Fitch KV; Kanter JR; Hemphill LC; Connelly JM; Lees RS; Lee H; Grinspoon S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4916-24. PubMed ID: 17003092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical carotid atherosclerosis and cardiovascular risk factors in HIV-infected patients.
    Kwiatkowska W; Knysz B; Drelichowska-Durawa J; Czarnecki M; Gąsiorowski J; Biłyk E; Karczewski M; Witkiewicz W
    Postepy Hig Med Dosw (Online); 2011 Nov; 65():770-83. PubMed ID: 22173442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical atherosclerosis in low Framingham risk HIV patients.
    León R; Reus S; López N; Portilla I; Sánchez-Payá J; Giner L; Boix V; Merino E; Torrús D; Moreno-Pérez Ó; Portilla J
    Eur J Clin Invest; 2017 Aug; 47(8):591-599. PubMed ID: 28664622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound measurements of carotid intima-media thickness and plaque in HIV-infected patients on the Mediterranean diet.
    Višković K; Rutherford GW; Sudario G; Stemberger L; Brnić Z; Begovac J
    Croat Med J; 2013 Aug; 54(4):330-8. PubMed ID: 23986273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.
    Lorenz MW; Stephan C; Harmjanz A; Staszewski S; Buehler A; Bickel M; von Kegler S; Ruhkamp D; Steinmetz H; Sitzer M
    Atherosclerosis; 2008 Feb; 196(2):720-6. PubMed ID: 17275008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection.
    Bellinati PQ; Alfieri DF; Flauzino T; Junior PFG; Rossi DJ; Breganó JW; Simão ANC; de Almeida ERD; Lozovoy MAB; Reiche EMV
    Curr HIV Res; 2020; 18(4):292-306. PubMed ID: 32516102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation.
    Parra S; Coll B; Aragonés G; Marsillach J; Beltrán R; Rull A; Joven J; Alonso-Villaverde C; Camps J
    HIV Med; 2010 Apr; 11(4):225-31. PubMed ID: 19845792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical factors and biomarkers associated with subclinical atherosclerosis in the human immunodeficiency virus infection].
    Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; Sánchez-Parra C; Sainz T; de Carranza M; Fernández-Cruz A
    Med Clin (Barc); 2012 Sep; 139(6):231-7. PubMed ID: 22440139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.
    Mercié P; Thiébaut R; Lavignolle V; Pellegrin JL; Yvorra-Vives MC; Morlat P; Ragnaud JM; Dupon M; Malvy D; Bellet H; Lawson-Ayayi S; Roudaut R; Dabis F
    Ann Med; 2002; 34(1):55-63. PubMed ID: 12014436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment.
    Bernal Morell E; Serrano Cabeza J; Muñoz Á; Marín I; Masiá M; Gutiérrez F; Cano A
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):648-53. PubMed ID: 27005326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.